125 related articles for article (PubMed ID: 28092772)
41. Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia.
Kushwaha G; Dozmorov M; Wren JD; Qiu J; Shi H; Xu D
Hum Genomics; 2016 Jul; 10 Suppl 2(Suppl 2):18. PubMed ID: 27461342
[TBL] [Abstract][Full Text] [Related]
42. Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes.
Sherry B; Jain P; Chiu PY; Leung L; Allen SL; Kolitz JE; Rai KR; Barrientos J; Liang S; Hawtin R; Chiorazzi N
Immunol Res; 2015 Dec; 63(1-3):216-27. PubMed ID: 26478573
[TBL] [Abstract][Full Text] [Related]
43. Aberrant TIRAP and MyD88 expression in B-cell chronic lymphocytic leukemia.
Antosz H; Sajewicz J; Marzec-Kotarska B; Dmoszyńska A; Baszak J; Jargiełło-Baszak M
Blood Cells Mol Dis; 2013 Jun; 51(1):48-55. PubMed ID: 23419703
[TBL] [Abstract][Full Text] [Related]
44. Molecular heterogeneity in chronic lymphocytic leukemia is dependent on BCR signaling: clinical correlation.
Rodríguez A; Villuendas R; Yáñez L; Gómez ME; Díaz R; Pollán M; Hernández N; de la Cueva P; Marín MC; Swat A; Ruiz E; Cuadrado MA; Conde E; Lombardía L; Cifuentes F; Gonzalez M; García-Marco JA; Piris MA;
Leukemia; 2007 Sep; 21(9):1984-91. PubMed ID: 17611561
[TBL] [Abstract][Full Text] [Related]
45. The expression of sphingosine-1 phosphate receptor-1 in chronic lymphocytic leukemia cells is impaired by tumor microenvironmental signals and enhanced by piceatannol and R406.
Borge M; Remes Lenicov F; Nannini PR; de los Ríos Alicandú MM; Podaza E; Ceballos A; Fernández Grecco H; Cabrejo M; Bezares RF; Morande PE; Oppezzo P; Giordano M; Gamberale R
J Immunol; 2014 Sep; 193(6):3165-74. PubMed ID: 25127862
[TBL] [Abstract][Full Text] [Related]
46. Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia.
Chen SS; Raval A; Johnson AJ; Hertlein E; Liu TH; Jin VX; Sherman MH; Liu SJ; Dawson DW; Williams KE; Lanasa M; Liyanarachchi S; Lin TS; Marcucci G; Pekarsky Y; Davuluri R; Croce CM; Guttridge DC; Teitell MA; Byrd JC; Plass C
Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13433-8. PubMed ID: 19666576
[TBL] [Abstract][Full Text] [Related]
47. Loss of cooperativity of secreted CD40L and increased dose-response to IL4 on CLL cell viability correlates with enhanced activation of NF-kB and STAT6.
Bhattacharya N; Reichenzeller M; Caudron-Herger M; Haebe S; Brady N; Diener S; Nothing M; Döhner H; Stilgenbauer S; Rippe K; Mertens D
Int J Cancer; 2015 Jan; 136(1):65-73. PubMed ID: 24828787
[TBL] [Abstract][Full Text] [Related]
48. Signalling to drug resistance in CLL.
Hertlein E; Byrd JC
Best Pract Res Clin Haematol; 2010 Mar; 23(1):121-31. PubMed ID: 20620976
[TBL] [Abstract][Full Text] [Related]
49. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
[TBL] [Abstract][Full Text] [Related]
50. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.
Halldórsdóttir AM; Kanduri M; Marincevic M; Mansouri L; Isaksson A; Göransson H; Axelsson T; Agarwal P; Jernberg-Wiklund H; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R
Am J Hematol; 2012 Apr; 87(4):361-7. PubMed ID: 22374828
[TBL] [Abstract][Full Text] [Related]
51. Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: Impact on EZH2 expression.
Kopparapu PK; Bhoi S; Mansouri L; Arabanian LS; Plevova K; Pospisilova S; Wasik AM; Croci GA; Sander B; Paulli M; Rosenquist R; Kanduri M
Epigenetics; 2016 May; 11(5):335-43. PubMed ID: 27052808
[TBL] [Abstract][Full Text] [Related]
52. Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia.
Motiwala T; Majumder S; Kutay H; Smith DS; Neuberg DS; Lucas DM; Byrd JC; Grever M; Jacob ST
Clin Cancer Res; 2007 Jun; 13(11):3174-81. PubMed ID: 17545520
[TBL] [Abstract][Full Text] [Related]
53. Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells.
Secchiero P; Corallini F; Barbarotto E; Melloni E; di Iasio MG; Tiribelli M; Zauli G
J Cell Physiol; 2006 Apr; 207(1):158-64. PubMed ID: 16270354
[TBL] [Abstract][Full Text] [Related]
54. Targeting inhibitor of apoptosis proteins by Smac mimetic elicits cell death in poor prognostic subgroups of chronic lymphocytic leukemia.
Opel D; Schnaiter A; Dodier D; Jovanovic M; Gerhardinger A; Idler I; Mertens D; Bullinger L; Stilgenbauer S; Fulda S
Int J Cancer; 2015 Dec; 137(12):2959-70. PubMed ID: 26096065
[TBL] [Abstract][Full Text] [Related]
55. Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells.
Bruno S; Ledda B; Tenca C; Ravera S; Orengo AM; Mazzarello AN; Pesenti E; Casciaro S; Racchi O; Ghiotto F; Marini C; Sambuceti G; DeCensi A; Fais F
Oncotarget; 2015 Sep; 6(26):22624-40. PubMed ID: 26265439
[TBL] [Abstract][Full Text] [Related]
56. Cohesin RAD21 Gene Promoter Methylation in Patients with Chronic Lymphocytic Leukemia.
Ioannidou A; Zachaki S; Karakosta M; Daraki A; Roussou P; Manola KN
Cytogenet Genome Res; 2018; 154(3):126-131. PubMed ID: 29587287
[TBL] [Abstract][Full Text] [Related]
57. DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia.
Wang LQ; Chim CS
Epigenomics; 2015; 7(3):461-73. PubMed ID: 25650645
[TBL] [Abstract][Full Text] [Related]
58. Sex-related DNA methylation differences in B cell chronic lymphocytic leukemia.
Lin S; Liu Y; Goldin LR; Lyu C; Kong X; Zhang Y; Caporaso NE; Xiang S; Gao Y
Biol Sex Differ; 2019 Jan; 10(1):2. PubMed ID: 30616686
[TBL] [Abstract][Full Text] [Related]
59. Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL.
Wierzbinska JA; Toth R; Ishaque N; Rippe K; Mallm JP; Klett LC; Mertens D; Zenz T; Hielscher T; Seifert M; Küppers R; Assenov Y; Lutsik P; Stilgenbauer S; Roessner PM; Seiffert M; Byrd J; Oakes CC; Plass C; Lipka DB
Genome Med; 2020 Mar; 12(1):29. PubMed ID: 32188505
[TBL] [Abstract][Full Text] [Related]
60. Toll-like receptor 9 signaling in chronic lymphocytic leukemia cell lines.
Meloni M; Sana I; Mantione ME; Riba M; Muzio M
FEBS Open Bio; 2023 Dec; 13(12):2367-2374. PubMed ID: 37881888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
